The pro-apoptotic protein caspase 3 acts as a dominant execution protease in tumor cell apoptosis, and the therapeutic response rate of NSCLC cells is correlated with the expression level of cleaved caspase 3. This evidence concerns the gene CASP3 and neoplasm.